---
title: "MRI-Derived Abdominal Subcutaneous Fat And Heart Failure Risk"
id: "medrxiv-5-mri-derived-fat-depots-and-cardiometabolic-pathways-underlying-heart-failure"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-5-mri-derived-fat-depots-and-cardiometabolic-pathways-underlying-heart-failure"
content_type: "clinical_feed_article"
specialty: "Research Highlights"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.06.26357230v1?rss=1"
published_at: "2026-07-10T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# MRI-Derived Abdominal Subcutaneous Fat And Heart Failure Risk
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-5-mri-derived-fat-depots-and-cardiometabolic-pathways-underlying-heart-failure
- **Specialty:** [Research Highlights](https://medichelpline.com/clinical-feed/research-highlights.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.06.26357230v1?rss=1)
- **Published At:** 2026-07-10T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
Background: Obesity is a major modifiable risk factor for heart failure (HF), but body mass index (BMI) does not distinguish biologically distinct fat depots. Whether imaging-derived adipose tissue depots capture specific cardiometabolic pathways underlying HF risk beyond conventional anthropometric measures remains uncertain. Methods: We performed two-sample Mendelian randomization (MR) and multivariable MR mediation analyses using published genome-wide association study summary statistics. General adiposity traits included BMI, waist-to-hip ratio (WHR), and WHR adjusted for BMI from GIANT and UK Biobank meta-analyses of up to 694,649 individuals. MRI-derived visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), and gluteofemoral adipose tissue (GFAT) were derived from 38,965 UK Biobank participants. HF outcome data were obtained from the HERMES consortium, including 1,946,349 individuals and 153,174 HF cases. Cardiometabolic mediators included type 2 diabetes (T2D), systolic blood pressure (SBP), LDL cholesterol, HDL cholesterol, and triglycerides. Primary analyses used inverse-variance weighted MR, with sensitivity analyses and directionality testing. Mediation was estimated using joint multivariable MR conditioning on significant cardiometabolic mediators.
## Clinical Analysis & Structured Key Points
medRxiv (Clinical Preprints) published a clinical update in Research Highlights on 10 Jul 2026. The item focuses on MRI-Derived Fat Depots and Cardiometabolic Pathways Underlying Heart Failure Risk: A Mendelian Randomization Study. Review the original article for the full source wording and details.
## Related Clinical Research

- [Minor Cardiac Dysfunction Linked To Later Brain Changes In Study](https://medichelpline.com/clinical-feed/medical-news-today-0-even-the-smallest-heart-issues-may-raise-dementia-risk-new-study-finds.md)
- [Lifestyle Changes May Help Prevent Multimorbidity In Prediabetes](https://medichelpline.com/clinical-feed/medical-news-today-23-diet-weight-loss-and-150-minutes-of-exercise-may-protect-against-chronic.md)
- [Sanofi Pompe drug shortages, Jazz Pharma buys Actio, and Lilly’s Foundayo OKed in U.K.](https://medichelpline.com/clinical-feed/stat-news-4-stat-pharmalittle-we-re-reading-about-a-sanofi-drug-shortage-a-jazz-pharma-deal.md)
- [SGLT2 Inhibitors and Rheumatoid Arthritis Risk in Type 2 Diabetes: Summary of Reported Emulated Ta](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-the-association-between-sglt2-inhibitors-and-rheumatoid-arthritis-risk-in-type.md)
- [Global Experts Update Heart Failure Definition and Classification](https://medichelpline.com/clinical-feed/aha-news-10-global-experts-update-heart-failure-definition-to-improve-prevention-diagnosis.md)

## Navigation
- [← Back to Research Highlights Feed](https://medichelpline.com/clinical-feed/research-highlights.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.